This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Acorda Therapeutics Gestione
Gestione criteri di controllo 2/4
Acorda Therapeutics' CEO is Ron Cohen, appointed in Jan 1995, has a tenure of 29.5 years. total yearly compensation is $996.33K, comprised of 62.7% salary and 37.3% bonuses, including company stock and options. directly owns 0.6% of the company’s shares, worth €1.14K. The average tenure of the management team and the board of directors is 6.2 years and 21 years respectively.
Informazioni chiave
Ron Cohen
Amministratore delegato
US$996.3k
Compenso totale
| Percentuale dello stipendio del CEO | 62.7% |
| Mandato del CEO | 29.5yrs |
| Proprietà del CEO | 0.6% |
| Durata media del management | 6.2yrs |
| Durata media del Consiglio di amministrazione | 21yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$263m |
| Dec 31 2023 | US$996k | US$625k | -US$253m |
| Sep 30 2023 | n/a | n/a | -US$16m |
| Jun 30 2023 | n/a | n/a | -US$21m |
| Mar 31 2023 | n/a | n/a | -US$58m |
| Dec 31 2022 | US$984k | US$625k | -US$66m |
| Sep 30 2022 | n/a | n/a | -US$106m |
| Jun 30 2022 | n/a | n/a | -US$119m |
| Mar 31 2022 | n/a | n/a | -US$95m |
| Dec 31 2021 | US$2m | US$743k | -US$104m |
| Sep 30 2021 | n/a | n/a | -US$166m |
| Jun 30 2021 | n/a | n/a | -US$132m |
| Mar 31 2021 | n/a | n/a | -US$127m |
| Dec 31 2020 | US$2m | US$796k | -US$100m |
| Sep 30 2020 | n/a | n/a | US$49m |
| Jun 30 2020 | n/a | n/a | -US$222m |
| Mar 31 2020 | n/a | n/a | -US$232m |
| Dec 31 2019 | US$2m | US$796k | -US$273m |
| Sep 30 2019 | n/a | n/a | -US$329m |
| Jun 30 2019 | n/a | n/a | -US$79m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | US$2m | US$796k | US$34m |
| Sep 30 2018 | n/a | n/a | -US$147m |
| Jun 30 2018 | n/a | n/a | -US$158m |
| Mar 31 2018 | n/a | n/a | -US$213m |
| Dec 31 2017 | US$2m | US$792k | -US$223m |
Compensazione vs Mercato: Ron's total compensation ($USD996.33K) is above average for companies of similar size in the German market ($USD515.52K).
Compensazione vs guadagni: Ron's compensation has increased whilst the company is unprofitable.
AMMINISTRATORE DELEGATO
Ron Cohen (68 yo)
29.5yrs
Mandato
US$996,328
Compensazione
Dr. Ron Cohen, M.D., serves as an Independent Director of ZWI Therapeutics, Inc. since January 2024. He has been the Founder of Acorda Therapeutics, Inc. since 1995 and has been its Chief Executive Officer...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Founder | 29.5yrs | US$996.33k | 0.60% $ 1.1k | |
| CFO & Treasurer | 2.7yrs | US$611.55k | 0% $ 0 | |
| General Counsel & Corporate Secretary | 2.7yrs | US$661.57k | 0% $ 0 | |
| Executive Vice President of Human Resources | 9.5yrs | Nessun dato | Nessun dato | |
| Chief Commercial Officer | 2.8yrs | US$592.23k | 0.041% $ 76.9 | |
| Senior VP of Operations & Strategic Planning | no data | Nessun dato | Nessun dato | |
| Senior VP of Drug Development & Regulatory Affairs | no data | Nessun dato | Nessun dato | |
| Special Scientific Advisor | no data | US$10.00k | Nessun dato |
6.2yrs
Durata media
64yo
Età media
Gestione esperta: CDG's management team is seasoned and experienced (6.2 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Founder | 29.5yrs | US$996.33k | 0.60% $ 1.1k | |
| Independent Director | 2.5yrs | US$94.71k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Director | 26.5yrs | US$82.65k | 0.0019% $ 3.7 | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Non-Executive Chairman | 15.6yrs | US$140.22k | 0% $ 0 |
21.0yrs
Durata media
70yo
Età media
Consiglio di amministrazione esperto: CDG's board of directors are seasoned and experienced ( 21 years average tenure).